Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populations

Knowledge of the involvement of the neurokinin substance P in emesis has led to the development of the neurokinin-1 receptor antagonists (NK-1 RAs) for control of chemotherapy-induced nausea and vomiting (CINV), in combination with serotonin type 3 receptor antagonists and corticosteroids. The NK-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Rapoport, Bernardo Leon, Aapro, Matti, Chasen, Martin R, Jordan, Karin, Navari, Rudolph M, Schnadig, Ian, Schwartzberg, Lee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592904/
https://www.ncbi.nlm.nih.gov/pubmed/28919712
http://dx.doi.org/10.2147/DDDT.S133943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592904/
https://www.ncbi.nlm.nih.gov/pubmed/28919712
http://dx.doi.org/10.2147/DDDT.S133943

Ejemplares similares